SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (25741)6/26/1999 8:01:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Your Bear Stearns report shows how absurd your earlier comment was:
Message 10252234

In case you missed LGND's latest press release, they filed an NDA for oral Targretin.

Using your active imagination, you used a Bear Stearns report on a possible topical Targretin filing by the 4Q of last year to somehow lend support to your comment that the oral NDA was 6-9 months late.

Obviously, LGND elected to file on oral first and there was no printed document predicting a 3Q '98 filing for oral Targretin for CTCL.

A few days ago, you said that this filing was 6-9 months late! Thus if my calculations are correct, you are saying that the filing was due in 3Q, 1998! Such a filing would have been a month after my post, and I had noted that LGND had said end of 1998, beginning of 1999, which I don't think gave any hint of a Sept, 1998 filing.

Thus, your comment on the NDA filing of oral being filed as early as Sept 1998 seems to have no support, and the existence of a LGND document indicating a 3Q, '98 filing is a figment of your imagination, at best.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext